Les substances hypotensives de l'urine humaine normale, CR Soc Biol, vol.66, pp.511-520, 1909. ,
Ein neues Kreislaufhormon und seine Wirkung, Naunyn-Schmiedebergs Archiv f??r Experimentelle Pathologie und Pharmakologie, vol.175, issue.Hft. 3/4, pp.1-56, 1928. ,
DOI : 10.1007/BF01955578
Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin, Am. J. Physiol, vol.156, pp.261-273, 1949. ,
Plasma kallikrein: the bradykinin-producing enzyme, Thrombosis and Haemostasis, vol.110, issue.3, pp.399-407, 2013. ,
DOI : 10.1160/TH13-03-0258
Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by Surface Plasmon Resonance (BiaCore), Thrombosis and Haemostasis, vol.105, issue.6, pp.1053-1059, 2011. ,
DOI : 10.1160/TH10-09-0591
Identification and Characterization of Prolylcarboxypeptidase as an Endothelial Cell Prekallikrein Activator, Journal of Biological Chemistry, vol.277, issue.20, pp.17962-17969, 2002. ,
DOI : 10.1074/jbc.M106101200
Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII, Proc. Natl ,
DOI : 10.1073/pnas.022626899
[4] Factor XII: Hageman factor, In: Laszlo Lorand KGM, éditeur. Methods in Enzymology, pp.51-65, 1993. ,
DOI : 10.1016/0076-6879(93)22007-3
Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma, Biological Chemistry, vol.387, issue.2, pp.173-178, 2006. ,
DOI : 10.1515/BC.2006.023
Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates, Journal of Thrombosis and Haemostasis, vol.147, issue.Suppl. 1, pp.1341-1352, 2013. ,
DOI : 10.1111/jth.12295
Urate crystal--dependent cleavage of Hageman factor in human plasma and synovial fluid, J. Lab. Clin. Med, vol.95, pp.497-506, 1980. ,
The plasma bradykinin-forming pathways and its interrelationships with complement, Molecular Immunology, vol.47, issue.13, pp.2161-2169, 2010. ,
DOI : 10.1016/j.molimm.2010.05.010
Whale High-Molecular-Weight and Low-Molecular-Weight Kininogens, Thrombosis Research, vol.97, issue.6, pp.481-490, 2000. ,
DOI : 10.1016/S0049-3848(99)00199-1
Bradykinin formation, Clinical Reviews in Allergy & Immunology, vol.2, issue.1, pp.403-429, 1998. ,
DOI : 10.1007/BF02737659
Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis, J. Immunol, vol.138, pp.428-434, 1987. ,
C1 inhibitor, a multi-functional serine protease inhibitor, Thrombosis and Haemostasis, vol.104, issue.5, pp.886-893, 2010. ,
DOI : 10.1160/TH10-01-0073
Contact System Activation in Patients with HAE and Normal C1??Inhibitor Function, Immunology and Allergy Clinics of North America, vol.33, issue.4, pp.513-533, 2013. ,
DOI : 10.1016/j.iac.2013.07.007
Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence, J. Biol. Chem, vol.267, pp.25873-25880, 1992. ,
-Protease Inhibitor), Hoppe-Seyler??s Zeitschrift f??r physiologische Chemie, vol.362, issue.1, pp.317-325, 1981. ,
DOI : 10.1515/bchm2.1981.362.1.317
URL : https://hal.archives-ouvertes.fr/jpa-00210010
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma, Am. J. Physiol. Heart Circ. Physiol, vol.281, pp.275-83, 2001. ,
An in vivo estimation of the potencies and half-lives of synthetic bradykinin and kallidin, J. Pharmacol. Exp. Ther, vol.148, pp.117-122, 1965. ,
Cardiovascular effects of Sar-[d- Phe8]des-Arg9-Bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide, J. Pharmacol. Exp. Ther, vol.280, pp.6-15, 1997. ,
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins, Peptides, vol.21, issue.12, 2000. ,
DOI : 10.1016/S0196-9781(00)00348-X
Targeting the ???Janus face' of the B2-bradykinin receptor, Expert Opinion on Therapeutic Targets, vol.24, issue.9, pp.1145-1166, 2013. ,
DOI : 10.1038/sj.bjp.0706982
Human recombinant membrane-bound aminopeptidase P: production of a soluble form and characterization using novel, internally quenched fluorescent substrates, Biochemical Journal, vol.385, issue.2, pp.389-397, 2005. ,
DOI : 10.1042/BJ20040849
Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.15, issue.3, pp.221-229, 2007. ,
DOI : 10.1007/s00210-007-0145-y
Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P, Biochemical Pharmacology, vol.42, issue.4, pp.721-727, 1991. ,
DOI : 10.1016/0006-2952(91)90028-4
A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema, Human Mutation, vol.23, issue.11, pp.1326-1331, 2011. ,
DOI : 10.1002/humu.21579
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences, Pharmacological Reviews, vol.57, issue.1, pp.27-77, 2005. ,
DOI : 10.1124/pr.57.1.2
Bradykinin-induced Internalization of the Human B2Receptor Requires Phosphorylation of Three Serine and Two Threonine Residues at Its Carboxyl Tail, Journal of Biological Chemistry, vol.274, issue.18, pp.12738-12747, 1999. ,
DOI : 10.1074/jbc.274.18.12738
Bradykinin B2 receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates, J. Pharmacol. Exp. Ther, vol.297, pp.19-26, 2001. ,
The Kallikrein-Kinin System: Current and Future Pharmacological Targets, Journal of Pharmacological Sciences, vol.99, issue.1, pp.6-38, 2005. ,
DOI : 10.1254/jphs.SRJ05001X
Differential pharmacology of cloned human and mouse B2 bradykinin receptors, Mol. Pharmacol, vol.45, pp.1-8, 1994. ,
receptor in 293 cells: pharmacological and functional characterization, British Journal of Pharmacology, vol.277, issue.2, pp.393-399, 1997. ,
DOI : 10.1038/sj.bjp.0701380
Structure???activity relationships of novel peptide agonists of the human bradykinin B2 receptor, Peptides, vol.30, issue.4, pp.777-787, 2009. ,
DOI : 10.1016/j.peptides.2008.12.003
Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist, Biological Chemistry, vol.394, issue.3, pp.353-360, 2013. ,
DOI : 10.1515/hsz-2012-0295
Bioregulation of kinins: kallikreins, kininogens, and kininases, Pharmacol. Rev, vol.44, pp.1-80, 1992. ,
Kinin receptors in pain and inflammation, European Journal of Pharmacology, vol.429, issue.1-3, pp.161-176, 2001. ,
DOI : 10.1016/S0014-2999(01)01318-8
Kallikrein cascade and cytokines in inflamed joints, Pharmacology & Therapeutics, vol.94, issue.1-2, pp.1-34, 2002. ,
DOI : 10.1016/S0163-7258(02)00166-3
Knee osteoarthritis: a role for bradykinin?, Inflammation Research, vol.57, issue.8, pp.351-361, 2008. ,
DOI : 10.1007/s00011-007-7204-1
Cleavage of high molecular weight kininogen in ascites and plasma of patients with cirrhosis, Thrombosis Research, vol.78, issue.4, pp.277-282, 1995. ,
DOI : 10.1016/0049-3848(95)00060-5
Pathophysiology of Acute Pancreatitis: Potential Application from Experimental Models and Human Medicine to Dogs, Journal of Veterinary Internal Medicine, vol.13, issue.Suppl 1, pp.875-887, 2012. ,
DOI : 10.1111/j.1939-1676.2012.00949.x
Therapeutic potential of icatibant (HOE-140 ,
Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In??Vivo, Immunity, vol.34, issue.2, pp.258-268, 2011. ,
DOI : 10.1016/j.immuni.2011.02.008
A Novel Mechanism for Bradykinin Production at Inflammatory Sites. DIVERSE EFFECTS OF A MIXTURE OF NEUTROPHIL ELASTASE AND MAST CELL TRYPTASE VERSUS TISSUE AND PLASMA KALLIKREINS ON NATIVE AND OXIDIZED KININOGENS, Journal of Biological Chemistry, vol.273, issue.50, pp.33224-33229, 1998. ,
DOI : 10.1074/jbc.273.50.33224
Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [dArg0-Hyp3-dPhe7]bradykinin, Biochemical Pharmacology, vol.41, issue.2, pp.293-300, 1991. ,
DOI : 10.1016/0006-2952(91)90489-R
]???Bradykinin Alters Migration and Production of Interleukin-12 in Monocyte-Derived Dendritic Cells, American Journal of Respiratory Cell and Molecular Biology, vol.45, issue.3, pp.542-549, 2011. ,
DOI : 10.1165/rcmb.2010-0238OC
Kinins and kinin receptors: importance for the activation of leukocytes, J. Leukoc. Biol, vol.68, pp.587-592, 2000. ,
Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity, J. Immunol, vol.157, pp.3122-3129, 1996. ,
FAMILIAL AGGREGATION OF URINARY KALLIKREIN CONCENTRATION IN CHILDHOOD: RELATION TO BLOOD PRESSURE, RACE AND URINARY ELECTROLYTES1, American Journal of Epidemiology, vol.104, issue.2, pp.124-132, 1976. ,
DOI : 10.1093/oxfordjournals.aje.a112282
Bradykinin as a vasodilator in man, The Journal of Physiology, vol.157, issue.3, pp.589-602, 1961. ,
DOI : 10.1113/jphysiol.1961.sp006745
Bradykinin in the treatment of arterial hypertension: friend or foe?, Hellenic J. Cardiol, vol.53, pp.91-94, 2012. ,
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors, Pharmacol. Rev, vol.47, pp.25-49, 1995. ,
The kallikrein???kinin system and oxidative stress, Current Opinion in Nephrology and Hypertension, vol.21, issue.1, pp.92-96, 2012. ,
DOI : 10.1097/MNH.0b013e32834d54b1
Impact of kinins in the treatment of cardiovascular diseases, Pharmacology & Therapeutics, vol.135, issue.1, pp.94-111, 2012. ,
DOI : 10.1016/j.pharmthera.2012.04.002
Hageman factor, platelets and polyphosphates: early history and recent connection, Journal of Thrombosis and Haemostasis, vol.8, issue.Suppl. 1, pp.1670-1674, 2010. ,
DOI : 10.1111/j.1538-7836.2010.03893.x
Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex, Blood, vol.90, pp.1508-1515, 1997. ,
In vivo roles of factor XII, Blood, vol.120, issue.22, pp.4296-4303, 2012. ,
DOI : 10.1182/blood-2012-07-292094
A FAMILIAL HEMORRHAGIC TRAIT ASSOCIATED WITH A DEFICIENCY OF A CLOT-PROMOTING FRACTION OF PLASMA 1, Journal of Clinical Investigation, vol.34, issue.4, pp.602-613, 1955. ,
DOI : 10.1172/JCI103109
Studies on Fletcher trait and Fitzgerald trait, Thrombosis and Haemostasis, vol.104, issue.5, pp.867-874, 2010. ,
DOI : 10.1160/TH10-01-0058
Prekallikrein (Fletcher factor) deficiency. Ann, Clin. Lab. Sci, vol.15, pp.279-285, 1985. ,
The many faces of the contact pathway and their role in thrombosis, Journal of Thrombosis and Thrombolysis, vol.49, issue.26, pp.9-20, 2011. ,
DOI : 10.1007/s11239-011-0578-5
The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments., Journal of Clinical Investigation, vol.62, issue.1, pp.54-60, 1978. ,
DOI : 10.1172/JCI109113
Activation of plasminogen by human plasma kallikrein, Biochemical and Biophysical Research Communications, vol.35, issue.2, pp.273-279, 1969. ,
DOI : 10.1016/0006-291X(69)90278-2
Bradykinin Stimulates Tissue Plasminogen Activator Release From Human Forearm Vasculature Through B2 Receptor-Dependent, NO Synthase-Independent, and Cyclooxygenase-Independent Pathway, Circulation, vol.102, issue.18, pp.2190-2196, 2000. ,
DOI : 10.1161/01.CIR.102.18.2190
Kinin-B2 Receptor Mediated Neuroprotection after NMDA Excitotoxicity Is Reversed in the Presence of Kinin-B1 Receptor Agonists, PLoS ONE, vol.59, issue.2, p.30755, 2012. ,
DOI : 10.1371/journal.pone.0030755.s001
Ischemia/reperfusion injury: Effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition, Biochemical Pharmacology, vol.88, issue.1, pp.12-22, 2014. ,
DOI : 10.1016/j.bcp.2013.12.013
(1)-receptors are induced by myocardial ischaemia-reperfusion in the rabbit, Endothelial kinin B J. Physiol, vol.530, pp.69-78, 2001. ,
Role of bradykinin in preconditioning and protection of the ischaemic myocardium, British Journal of Pharmacology, vol.98, issue.suppl 3A, pp.843-854, 2002. ,
DOI : 10.1038/sj.bjp.0704548
Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice, International Immunopharmacology, vol.2, issue.6, pp.815-822, 2002. ,
DOI : 10.1016/S1567-5769(02)00022-X
Effects of Bradykinin Postconditioning on Endogenous Antioxidant Enzyme Activity After Transient Forebrain Ischemia in Rat, Neurochemical Research, vol.59, issue.Suppl 1, pp.1057-1064, 2008. ,
DOI : 10.1007/s11064-007-9550-3
Receptor in a Murine Model of Diffuse Brain Injury, Journal of Neurotrauma, vol.20, issue.9, pp.841-851, 2003. ,
DOI : 10.1089/089771503322385773
Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury, Free Radical Biology and Medicine, vol.41, issue.8, pp.1304-1314, 2006. ,
DOI : 10.1016/j.freeradbiomed.2006.07.011
receptor for the local and systemic inflammatory response that follows severe reperfusion injury, British Journal of Pharmacology, vol.48, issue.1, pp.129-139, 2003. ,
DOI : 10.1038/sj.bjp.0705200
Cardioprotective properties of bradykinin: role of the B2 receptor, Hypertension Research, vol.70, issue.8, pp.772-777, 2010. ,
DOI : 10.1038/hr.2010.82
Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection From Cerebral Infarction and Brain Edema * Expanded Materials and Methods, Stroke, vol.40, issue.1, pp.285-293, 2009. ,
DOI : 10.1161/STROKEAHA.108.526673
The kallikrein???kinin system in health and in diseases of the kidney, Kidney International, vol.75, issue.10, pp.1019-1030, 2009. ,
DOI : 10.1038/ki.2008.647
The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway, The FASEB Journal, vol.15, pp.1487-1489, 2001. ,
DOI : 10.1096/fj.00-0503fje
Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells, Biochemical Pharmacology, vol.87, issue.2, pp.243-253, 2014. ,
DOI : 10.1016/j.bcp.2013.10.016
Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling, Thrombosis and Haemostasis, vol.104, issue.5, pp.875-885, 2010. ,
DOI : 10.1160/TH10-01-0017
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen., Journal of Clinical Investigation, vol.72, issue.5, pp.1678-1685, 1983. ,
DOI : 10.1172/JCI111127
Kinin Formation: Mechanisms and Role in Inflammatory Disorders, Annual Review of Immunology, vol.6, issue.1, pp.49-83, 1988. ,
DOI : 10.1146/annurev.iy.06.040188.000405
Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications, Diabetes, vol.43, issue.3, pp.384-388, 1994. ,
DOI : 10.2337/diab.43.3.384
receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients, Canadian Journal of Physiology and Pharmacology, vol.80, issue.4, pp.323-327, 2002. ,
DOI : 10.1139/y02-036
Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron, AJP: Renal Physiology, vol.300, issue.5, pp.1105-1115, 2011. ,
DOI : 10.1152/ajprenal.00606.2010
Blockade of renal medullary bradykinin B2 receptors increases tubular sodium reabsorption in rats fed a normal-salt diet, AJP: Renal Physiology, vol.295, issue.3, pp.811-817, 2008. ,
DOI : 10.1152/ajprenal.90225.2008
The kinin???kallikrein system: physiological roles, pathophysiology and its relationship to cancer biomarkers, Biomarkers, vol.286, issue.4, pp.279-296, 2013. ,
DOI : 10.1080/02688690500305555
Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues, International Journal of Cancer, vol.63, issue.suppl, pp.29-35, 2002. ,
DOI : 10.1002/ijc.10142
Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting, Proceedings of the Japan Academy, Series B, vol.88, issue.3, pp.53-71, 2012. ,
DOI : 10.2183/pjab.88.53
The kallikrein???kinin-system in head and neck squamous cell carcinoma (HNSCC) and its role in tumour survival, invasion, migration and response to radiotherapy, Oral Oncology, vol.48, issue.12, pp.1208-1219, 2012. ,
DOI : 10.1016/j.oraloncology.2012.06.001
Role of the B2 Receptor of Bradykinin in Insulin Sensitivity, Hypertension, vol.38, issue.6, pp.1355-1360, 2001. ,
DOI : 10.1161/hy1201.096574
Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance, Diabetes, Obesity and Metabolism, vol.41, issue.4, pp.214-222, 2003. ,
DOI : 10.1016/S0895-7061(99)00174-0
Increased bradykinin and ???normal??? angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats, Kidney International, vol.56, issue.1, pp.211-221, 1999. ,
DOI : 10.1046/j.1523-1755.1999.00519.x
Characterization of a novel proinflammatory effect mediated by BK and the kinin B2 receptor in human preadipocytes, Biochemical Pharmacology, vol.86, issue.4, pp.508-520, 2013. ,
DOI : 10.1016/j.bcp.2013.06.005
Lack of kinin B1 receptor potentiates leptin action in the liver, Journal of Molecular Medicine, vol.92, issue.7, pp.851-860, 2013. ,
DOI : 10.1007/s00109-013-1004-6
Synthesis of bradykinin fragments and their effect on pentobarbital sleeping time in mouse, Neuropharmacology, vol.16, issue.5, pp.381-383, 1977. ,
DOI : 10.1016/0028-3908(77)90076-4
Effects of intraventricular injection of bradykinin on the EEG and the blood pressure in conscious rats, Neuropharmacology, vol.20, issue.12, pp.1221-1224, 1981. ,
DOI : 10.1016/0028-3908(81)90068-X
Kinin Receptor Antagonists as Potential Neuroprotective Agents in Central Nervous System Injury, Molecules, vol.15, issue.9, pp.6598-6618, 2010. ,
DOI : 10.3390/molecules15096598
Interaction of Factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated A?? protein of Alzheimer's disease, Immunopharmacology, vol.43, issue.2-3, pp.203-210, 1999. ,
DOI : 10.1016/S0162-3109(99)00136-8
Assessment of activation of the plasma kallikrein-kinin system in frontal and temporal cortex in Alzheimer's disease and vascular dementia, Neurobiology of Aging, vol.33, issue.7, pp.1345-1355, 2012. ,
DOI : 10.1016/j.neurobiolaging.2010.09.024
The effect of kinin agonists and antagonists on the pain response of the human blister base, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.336, issue.6, pp.652-655, 1987. ,
DOI : 10.1007/BF00165756
Reduced Nerve Injury-Induced Neuropathic Pain in Kinin B1 Receptor Knock-Out Mice, Journal of Neuroscience, vol.25, issue.9, pp.2405-2412, 2005. ,
DOI : 10.1523/JNEUROSCI.2466-04.2005
Systemic treatment with Mycobacterium bovis bacillus calmette-guerin (BCG) potentiates kinin B1 receptor agonist-induced nociception and oedema formation in the formalin test in mice, Neuropeptides, vol.32, issue.5, pp.393-403, 1998. ,
DOI : 10.1016/S0143-4179(98)90062-2
Modulation of bradykinin-induced plasma extravasation in the rat knee joint by sympathetic co-transmitters, Neuroscience, vol.52, issue.2, pp.451-458, 1993. ,
DOI : 10.1016/0306-4522(93)90171-B
Kinins and kinin receptors in the nervous system, Neurochemistry International, vol.26, issue.1, pp.1-16, 1995. ,
DOI : 10.1016/0197-0186(94)00114-A
Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema, PLoS ONE, vol.61, issue.8, p.70140, 2013. ,
DOI : 10.1371/journal.pone.0070140.s001
Actualit??s biologiques sur les angioed??mes ?? kinines, Revue Francophone des Laboratoires, vol.2012, issue.444, pp.39-52, 2012. ,
DOI : 10.1016/S1773-035X(12)71616-7
SERPING1 mutations in 59 families with hereditary angioedema, Molecular Immunology, vol.49, issue.1-2, pp.18-27, 2011. ,
DOI : 10.1016/j.molimm.2011.07.010
Clinical and biological distinctions between type I and type II acquired angioedema, The American Journal of Medicine, vol.115, issue.5, pp.420-421, 2003. ,
DOI : 10.1016/S0002-9343(03)00396-6
A Variant in XPNPEP2 Is Associated with Angioedema Induced by Angiotensin I???Converting Enzyme Inhibitors, The American Journal of Human Genetics, vol.77, issue.4, pp.617-626, 2005. ,
DOI : 10.1086/496899
DNA polymorphism and mutations in CPN1 , including the genomic basis of carboxypeptidase N deficiency, Journal of Human Genetics, vol.48, issue.1, pp.20-22, 2003. ,
DOI : 10.1007/s100380300003
Angiotensin-Converting Enzyme (ACE) Inhibitor Angioedema: The Silent Epidemic, The American Journal of Cardiology, vol.109, issue.5, pp.774-775, 2012. ,
DOI : 10.1016/j.amjcard.2011.11.014
Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System, Archives of Internal Medicine, vol.172, issue.20, pp.1582-1589, 2012. ,
DOI : 10.1001/2013.jamainternmed.34
Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema, Hypertension, vol.54, issue.3, pp.516-523, 2009. ,
DOI : 10.1161/HYPERTENSIONAHA.109.134197
Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors, The Lancet, vol.359, issue.9323, pp.2088-2089, 2002. ,
DOI : 10.1016/S0140-6736(02)08914-6
Protease inhibitors in the treatment of hereditary angioedema, Transfusion and Apheresis Science, vol.29, issue.3, pp.259-267, 2003. ,
DOI : 10.1016/j.transci.2003.08.004
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency, Journal of Allergy and Clinical Immunology, vol.117, issue.4, pp.904-908, 2006. ,
DOI : 10.1016/j.jaci.2006.01.002
Receptors for bradykinin in rabbit aortae, Canadian Journal of Physiology and Pharmacology, vol.55, issue.4, pp.855-867, 1977. ,
DOI : 10.1139/y77-115
Structure-activity studies of bradykinin and related peptides. B2- receptor antagonists, Hypertension, vol.17, issue.1, pp.107-115, 1991. ,
DOI : 10.1161/01.HYP.17.1.107
The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist., Proc. Natl. Acad ,
DOI : 10.1073/pnas.91.11.4693
Nonpeptide antagonists for kinin receptors, Regulatory Peptides, vol.80, issue.1-2, pp.13-26, 1999. ,
DOI : 10.1016/S0167-0115(99)00003-8
Effects of the non-peptide B 2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation, Inflammation Research, vol.49, issue.10, pp.535-540, 2000. ,
DOI : 10.1007/s000110050628
Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin, J. Pharmacol. Exp. Ther, vol.269, pp.1136-1143, 1994. ,
0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor, Br. J. Pharmacol, vol.16125, pp.365-372, 1998. ,
Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist, Immunopharmacology, vol.43, issue.2-3, pp.187-194, 1999. ,
DOI : 10.1016/S0162-3109(99)00128-9
A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor, International Immunopharmacology, vol.3, issue.10-11, pp.1529-1536, 2003. ,
DOI : 10.1016/S1567-5769(03)00180-2
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies, British Journal of Pharmacology, vol.10, issue.Suppl. 1, pp.769-773, 1991. ,
DOI : 10.1111/j.1476-5381.1991.tb12248.x
Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species, British Journal of Pharmacology, vol.102, issue.Suppl. 6, pp.683-689, 1994. ,
DOI : 10.1111/j.1476-5381.1994.tb13130.x
Mutations in the B2 Bradykinin Receptor Reveal a Different Pattern of Contacts for Peptidic Agonists and Peptidic Antagonists, Journal of Biological Chemistry, vol.271, issue.45, pp.28277-28286, 1996. ,
DOI : 10.1074/jbc.271.45.28277
Pharmacological characterization of a new highly potent B2 receptor antagonist, HOE Eur. J. Pharmacol, vol.140210, issue.83, pp.115-120, 1992. ,
New, long-acting, potent bradykinin antagonists, British Journal of Pharmacology, vol.6, issue.2, pp.297-304, 1991. ,
DOI : 10.1111/j.1476-5381.1991.tb12169.x
In vitro effects of HOE 140 in human bronchial and vascular tissue, European Journal of Pharmacology, vol.274, issue.1-3, pp.57-64, 1995. ,
DOI : 10.1016/0014-2999(94)00709-G
Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies, British Journal of Pharmacology, vol.111, issue.3, pp.774-777, 1991. ,
DOI : 10.1111/j.1476-5381.1991.tb12249.x
Influence of a long-acting bradykinin antagonist, Hoe 140, on some acute inflammatory reactions in the rat, European Journal of Pharmacology, vol.211, issue.1, pp.81-86, 1992. ,
DOI : 10.1016/0014-2999(92)90266-7
Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig, European Journal of Pharmacology, vol.213, issue.3, pp.367-373, 1992. ,
DOI : 10.1016/0014-2999(92)90625-E
Effect of Hoe 140 on Bradykinin-induced Bronchoconstriction in Anesthetized Guinea Pigs, American Review of Respiratory Disease, vol.148, issue.3, pp.702-706, 1993. ,
DOI : 10.1164/ajrccm/148.3.702
Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist., British Journal of Clinical Pharmacology, vol.11, issue.suppl 4, pp.317-321, 1994. ,
DOI : 10.1111/j.1365-2125.1994.tb04360.x
Bradykinin B2 Receptor Antagonism Attenuates Blood Pressure Response to Acute Angiotensin-Converting Enzyme Inhibition in Normal Men, Hypertension, vol.36, issue.1, pp.132-136, 2000. ,
DOI : 10.1161/01.HYP.36.1.132
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant), Journal of Allergy and Clinical Immunology, vol.119, issue.6, pp.1497-1503, 2007. ,
DOI : 10.1016/j.jaci.2007.02.012
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema, New England Journal of Medicine, vol.363, issue.6, pp.532-541, 2010. ,
DOI : 10.1056/NEJMoa0906393
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema, Allergy, Asthma & Clinical Immunology, vol.6, issue.1, p.24, 2010. ,
DOI : 10.1186/1710-1492-6-24
Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial, Annals of Allergy, Asthma & Immunology, vol.107, issue.6, pp.529-537, 2011. ,
DOI : 10.1016/j.anai.2011.08.015
Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H1-antihistamines, Experimental Dermatology, vol.261, issue.11, pp.154-159, 2012. ,
DOI : 10.1111/j.1600-0625.2011.01410.x
Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant, Intensive Care Medicine, vol.40, issue.6, 2014. ,
DOI : 10.1007/s00134-014-3290-z
BRADYKININ RECEPTOR 2 ANTAGONIST (ICATIBANT) FOR HEREDITARY ANGIOEDEMA TYPE III ATTACKS, Annals of Allergy, Asthma & Immunology, vol.103, issue.5, p.448, 2009. ,
DOI : 10.1016/S1081-1206(10)60369-9
URL : https://hal.archives-ouvertes.fr/hal-00474261
Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series, Annals of Emergency Medicine, vol.56, issue.3, pp.278-282, 2010. ,
DOI : 10.1016/j.annemergmed.2010.03.032
Short-term prophylactic treatment of hereditary angioedema with icatibant, Allergy, vol.119, issue.1, pp.137-138, 2010. ,
DOI : 10.1111/j.1398-9995.2009.02160.x
Successful perioperative management of a patient with C1 esterase inhibitor deficiency with a novel bradykinin receptor B2 antagonist, Anaesth. Intensive Care, vol.40, pp.523-526, 2012. ,
Openlabel , multicenter study of self-administered icatibant for attacks of hereditary angioedema, Allergy, 2013. ,
Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment, PLoS ONE, vol.104, issue.2, p.53773, 2013. ,
DOI : 10.1371/journal.pone.0053773.s001
Cardiopulmonary bypass increases plasma bradykinin concentrations, Immunopharmacology, vol.43, issue.2-3, pp.145-147, 1999. ,
DOI : 10.1016/S0162-3109(99)00072-7
Contribution of Endogenous Bradykinin to Fibrinolysis, Inflammation, and Blood Product Transfusion Following Cardiac Surgery: A Randomized Clinical Trial, Clinical Pharmacology & Therapeutics, vol.86, issue.4, pp.326-334, 2013. ,
DOI : 10.1161/hy0302.105767
Bradykinin does not mediate remote ischaemic preconditioning or ischaemia-reperfusion injury in vivo in man, Heart, vol.97, issue.22, pp.1857-1861, 2011. ,
DOI : 10.1136/heartjnl-2011-300323
Bradykinin and its role in osteoarthritis, Reumatismo, vol.65, issue.3, pp.97-104, 2013. ,
DOI : 10.4081/reumatismo.2013.97
Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI, Annals of the Rheumatic Diseases, vol.68, issue.1, pp.75-83, 2009. ,
DOI : 10.1136/ard.2007.080382
Inhibition of the response to nasal provocation with bradykinin by HOE- 140: efficacy and duration of action, Canadian Journal of Physiology and Pharmacology, vol.73, issue.7, pp.820-826, 1995. ,
DOI : 10.1139/y95-111
Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage, British Journal of Pharmacology, vol.85, issue.4, pp.969-971, 1994. ,
DOI : 10.1111/j.1476-5381.1994.tb14835.x
Role of kinins in seasonal allergic rhinitis: Icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen, Journal of Allergy and Clinical Immunology, vol.107, issue.1, pp.105-113, 2001. ,
DOI : 10.1067/mai.2001.111145
Proof-of-concept study of icatibant (JE 049), a bradykinin B2 receptor antagonist in treatment of hereditary angioedema, Clinical Pharmacology & Therapeutics, vol.77, issue.2, p.14, 2005. ,
DOI : 10.1016/j.clpt.2004.11.055
Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma, Immunopharmacology, vol.33, issue.1-3, pp.238-242, 1996. ,
DOI : 10.1016/0162-3109(96)00065-3
A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Scand, J. Infect. Dis, vol.45, pp.494-496, 2013. ,
Possible Mediators for Systemic Capillary Leak Syndrome, The American Journal of Medicine, vol.124, issue.1, pp.7-9, 2011. ,
DOI : 10.1016/j.amjmed.2010.04.024
Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain, Pain, vol.86, issue.3, pp.265-271, 2000. ,
DOI : 10.1016/S0304-3959(00)00256-6
Genetic deletion or antagonism of kinin B1 and B2 receptors improves cognitive deficits in a mouse model of Alzheimer's disease, Neuroscience, vol.151, issue.3, pp.631-643, 2008. ,
DOI : 10.1016/j.neuroscience.2007.11.009
Treatment of Severe Systemic Inflammatory Response Syndrome and Sepsis With a Novel Bradykinin Antagonist, Deltibant (CP-0127)<subtitle>Results of a Randomized, Double-blind, Placebo-Controlled Trial</subtitle>, JAMA: The Journal of the American Medical Association, vol.277, issue.6, pp.482-487, 1997. ,
DOI : 10.1001/jama.1997.03540300050033
Bradykinin receptor 2 extends inflammatory cell recruitment in a model of acute gouty arthritis, Biochemical and Biophysical Research Communications, vol.416, issue.3-4, pp.266-269, 2011. ,
DOI : 10.1016/j.bbrc.2011.10.137
Inhibition of kinin action and kinin generation compared to dexamethasone pretreatment with respect to vascular effects and pancreatic enzymes in experimental acute pancreatitis, Immunopharmacology, vol.43, issue.2-3, pp.219-224, 1999. ,
DOI : 10.1016/S0162-3109(99)00093-4
Bradykinin antagonists: Development and applications, Biopolymers, vol.269, issue.2, pp.143-155, 1995. ,
DOI : 10.1002/bip.360370208
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency, Journal of Allergy and Clinical Immunology, vol.124, issue.6, pp.1303-1310, 2009. ,
DOI : 10.1016/j.jaci.2009.08.007
Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema, International Journal of Dermatology, vol.8, issue.10, pp.1294-1295, 2011. ,
DOI : 10.1111/j.1365-4632.2011.05051.x
Platelet-Activating Factor and Kinin-Dependent Vascular Leakage as a Novel Functional Activity of the Soluble Terminal Complement Complex, The Journal of Immunology, vol.173, issue.11, pp.6921-6927, 2004. ,
DOI : 10.4049/jimmunol.173.11.6921
Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research, Angiogenesis, vol.4, issue.2, pp.91-102, 2001. ,
DOI : 10.1023/A:1012259529167
Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-??. Effects dependent on activation of NF-??B and MAP kinases, Bone, vol.43, issue.1, pp.72-83, 2008. ,
DOI : 10.1016/j.bone.2008.02.003
Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems, Expert Opinion on Pharmacotherapy, vol.9, issue.15, pp.2233-2280, 2012. ,
DOI : 10.3390/molecules15096598